Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts
Anthony B. Rodriguez,J. David Peske,Amber N. Woods,Katie M. Leick,Ileana S. Mauldin,Max O. Meneveau,Samuel J. Young,Robin S. Lindsay,Marit M. Melssen,Salwador Cyranowski,Geoffrey Parriott,Mark R. Conaway,Yang-Xin Fu,Craig L. Slingluff,Victor H. Engelhard
DOI: https://doi.org/10.1016/j.celrep.2021.109422
IF: 8.8
2021-07-01
Cell Reports
Abstract:Tumor-associated tertiary lymphoid structures (TA-TLS) are associated with enhanced patient survival and responsiveness to cancer therapies, but the mechanisms underlying their development are unknown. We show here that TA-TLS development in murine melanoma is orchestrated by cancer-associated fibroblasts (CAF) with characteristics of lymphoid tissue organizer cells that are induced by tumor necrosis factor receptor signaling. CAF organization into reticular networks is mediated by CD8 T cells, while CAF accumulation and TA-TLS expansion depend on CXCL13-mediated recruitment of B cells expressing lymphotoxin-α<sub>1</sub>β<sub>2</sub>. Some of these elements are also overrepresented in human TA-TLS. Additionally, we demonstrate that immunotherapy induces more and larger TA-TLS that are more often organized with discrete T and B cell zones, and that TA-TLS presence, number, and size are correlated with reduced tumor size and overall response to checkpoint immunotherapy. This work provides a platform for manipulating TA-TLS development as a cancer immunotherapy strategy.
cell biology